A phase 3, open-label trial of neoadjuvant trastuzumab deruxtecan (T-DXd) monotherapy or T-DXd followed by THP vs ddAC-THP in high-risk HER2-positive early-stage breast cancer (DESTINY-Breast11) Meeting Abstract
| Authors: | Harbeck, N.; Boileau, J. F.; Modi, S.; Kelly, C.; Ohno, S.; Wu, J.; Konpa, A.; Herbolsheimer, P.; Safdar, S.; Zhang, Y.; Pusztai, L. |
| Abstract Title: | A phase 3, open-label trial of neoadjuvant trastuzumab deruxtecan (T-DXd) monotherapy or T-DXd followed by THP vs ddAC-THP in high-risk HER2-positive early-stage breast cancer (DESTINY-Breast11) |
| Meeting Title: | 18th St. Gallen International Breast Cancer Conference |
| Keywords: | oncology; obstetrics & gynecology |
| Journal Title: | Breast |
| Volume: | 68 |
| Issue: | Suppl. |
| Meeting Dates: | 2023 Mar 15-18 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 0960-9776 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-04-01 |
| Start Page: | S57 |
| Language: | English |
| ACCESSION: | WOS:001037996400124 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0960-9776(23)00228-X |
| Notes: | Meeting Abstract: P111 -- Source: Wos |
